The incidence of new-onset secondary atrial fibrillation (NOSAF) is as high as 44% in noncardiac critical illness. A systematic review and meta-analysis were performed to evaluate the impact of NOSAF, compared with history of prior atrial fibrillation (AF) and no history of AF in noncardiac critically ill patients. Patients undergoing cardiothoracic surgery were excluded. NOSAF incidence, intensive care unit (ICU)/hospital length of stay (LOS), and mortality outcomes were analyzed. Of 2,360 studies reviewed, 19 studies met inclusion criteria (n = 306,805 patients). NOSAF compared with no history of AF was associated with increased in-hospital mortality (risk ratio [RR] 2.06, 95% confidence interval [CI] 1.76 to 2.41, p <0.001), longer ICU LOS (standardized difference in means [SMD] 0.66, 95% CI 0.41 to 0.91, p <0.001), longer hospital LOS (SMD 0.31, 95% CI 0.07 to 0.56, p = 0.001) and increased risk of long-term (>1 year) mortality (RR 1.76, 95% CI 1.29 to 2.40, p <0.001). NOSAF compared with previous AF was also associated with higher in-hospital mortality (RR 1.29, 95% CI 1.12 to 1.49, p <0.001), longer ICU LOS (SMD 0.37, 95% CI 0.03 to 0.70, p = 0.03) but no difference in-hospital LOS (SMD −0.18, 95% CI −0.66 to 0.31, p = 0.47). In conclusion, NOSAF, in the setting of noncardiac critical illness is associated with increased in-hospital mortality compared with no history of AF and previous AF. NOSAF (vs no history of AF) is also associated with increased long-term mortality.
Atrial fibrillation (AF) is one of the most common arrhythmias with significant morbidity and mortality. Similar to previous studies, we defined new-onset secondary AF (NOSAF) as initial diagnosis of AF (without preexisting AF) that occurred during medical management of an unrelated noncardiac condition. A recent study showed increased prevalence of device detected AF around the time of noncardiac surgery or medical illness requiring hospitalization with half the patients having similar episodes in the past. Estimates of NOSAF occurrence in the critically ill population range up to 44%. One school of thought is that NOSAF occurs as an isolated event in the setting of acute illness and does not portend a poor prognosis in the long-term. Importantly, the general opinion is that NOSAF does not merit the same management strategies as a history of paroxysmal or persistent AF. This is especially relevant in noncardiac critical illness. With an emerging interest in NOSAF, we sought to analyze the outcomes in studies that evaluated NOSAF in noncardiac critically ill patients.
We included studies assessing noncardiac critically ill adult patients who developed NOSAF and had a comparator group with either no previous AF or previous AF presenting with or without AF in the index hospitalization. We excluded patients admitted for cardiovascular or thoracic surgery as they are known risk factors for the development of AF. The outcome data had to include either in-hospital mortality, hospital length of stay (LOS), intensive care unit (ICU) LOS, long-term mortality (≥1 year), or stroke. Articles had to be published in English and have full text available.
To identify eligible studies for inclusion in the systematic review and meta-analysis, 3 independent reviewers (KS, LS, and MK) systematically searched Cochrane CENTRAL, PubMed, United Kingdom Clinical Trials Gateway, and the WHO International Clinical Trials Registry for relevant studies. Search terms were “secondary,” “new-onset,” or “recent onset;” “atrial fibrillation,” “atrial flutter,” or “arrhythmia;” and “sepsis,” “critically ill,” “pneumonia,” or “acute disease”. In addition, we reviewed citations from the eligible studies. This review followed the MOOSE guidelines for meta-analysis reporting. Available studies were screened based on the title and abstract. Full text articles were obtained for studies that could be eligible. The eligibility of the articles was determined by the same reviewers by going through each article (n = 59). We collected data on author, year, study design, outcomes measured, follow-up rate. We collected absolute event counts. When studies reported matched and unmatched data, we collected both sets of data but used matched data for the analysis. Differences in study inclusion were resolved after discussion and consensus between the 3 reviewers or by a 4th reviewer, (NM), in case of disagreement. The study quality was assessed using the Newcastle-Ottawa Quality Assessment Scale for cohort studies, with scores over 7 indicating high quality. Clinical outcomes of interest were in-hospital mortality, hospital LOS, ICU LOS, stroke occurrence, and long-term mortality. Because all the data were extracted from published manuscripts, our study was exempt from institutional review board approval.
Statistical analysis was performed using meta package for R (version 4.0, R Foundation, Vienna, Austria) and RStudio (version 1.2, RStudio, PBC, Boston, Massachusetts). For binary data, Mantel-Haenszel risk ratio (RR) with random-effects model (DerSimonian and Laird method) was used to summarize data between the groups. For continuous data in the studies which were reported as median and interquartile range, we first used the Wan method to estimate the mean and SD. We then calculated the standardized difference in means (SMD) using a random effects model and Cohen’s d to evaluate the data between the groups. Higgins I-squared ( I 2 ) statistic was used to assess the heterogeneity. A value of I 2 of 0% to 25% represented insignificant heterogeneity, 26% to 50% represented low heterogeneity, 51% to 75% represented moderate heterogeneity, and more than 75% represented high heterogeneity. Sensitivity analysis was performed with leave-one-out method to evaluate influence of 1 study. Publication bias was formally assessed using funnel plots and Egger’s linear regression test of funnel plot asymmetry for outcomes reported in ≥10 studies. A 2-tailed p <0.05 was considered statistically significant.
Of the 2,360 relevant articles identified, 59 studies were adjudicated as relevant and underwent full-text review. Of these, 19 studies ultimately met the inclusion criteria and were included in the meta-analysis. , These studies comprised 306,805 participants ( Figure 1 ). A total of 11 studies were retrospective. , , , , , , The majority were conducted at a single center and there were 2 large database studies. Detailed study characteristics can be found in Table 1 . All studies were high quality except for the study by Brathwaite and Weissman which had a score of 4 ( Supplementary Table 1 ).
Study | Sample | Design | Population | Follow-Up (Years) |
---|---|---|---|---|
Arrigo et al | 1,841 | prospective, observational, multicenter, cohort | ICU | 1 |
Bedford et al | 7,541 | retrospective database | ICU | hospital discharge |
Brathwaite et al | 462 | prospective, observational, cohort | ICU | hospital discharge |
Carrera et al | 10,836 | retrospective single center cohort | ICU | 1 |
Chen et al | 741 | retrospective single center | ICU | hospital discharge |
Cheng et al | 68,324 | retrospective database | septic inpatient | hospital discharge |
Christian et al | 274 | retrospective observational cohort | septic, ICU | hospital discharge |
Fernando et al | 15,014 | retrospective observational | ICU | hospital discharge |
Goodman et al | 611 | prospective observation, cohort | ICU | 4 |
Guenancia et al | 66 | prospective observation cohort | ICU | hospital discharge |
Jacobs et al | 616 | retrospective cohort database | ICU | 3.9 |
Klouwenberg et al | 1,782 | prospective cohort | ICU | 1 |
Lewis et al | 131 | retrospective cohort | ICU | |
Liu et al | 503 | retrospective cohort | ICU with sepsis | hospital discharge |
Makrygiannis et al | 133 | prospective cohort | ICU | 1 |
Moss et al | 8,356 | prospective cohort | ICU | 1.4 |
Shaver et al | 1,770 | prospective cohort | ICU | hospital discharge |
Walkey et al | 49,082 | retrospective database | acute care admissions | hospital discharge |
Walkey et al | 138,722 | retrospective database | sepsis and hospitalized | 5 |
There were 18,882 patients who developed NOSAF in the 19 included studies. Across all studies, the mean age was 67.79 years. The mean percentage of women was 44%. Congestive heart failure, hypertension, and diabetes mellitus were common, with mean percentages of 22%, 56%, and 31%, respectively. Patient characteristics are summarized in Table 2 .
Study | NOSAF | ||||||||
---|---|---|---|---|---|---|---|---|---|
n | Age (y) | Female | Hypertension | DM | CHF | CAD | Stroke | Apache | |
Arrigo et al | 212 | 73 | 25% | 53% | 24% | 15% | 16% | 3% | NR |
Bedford et al | 831 | 71 | 40% | NR | NR | NR | NR | NR | NR |
Brathwaite et al | 47 | 67 | 55% | 47% | NR | 6.3% | 26% | NR | 8.4 |
Carrera et al | 582 | 72 | 43% | 68% | 32% | 13% | 26% | 12% | 60 |
Chen et al | 53 | 67 | 51% | NR | 34% | 25% | 28% | NR | 27 |
Cheng et al | 1,286 | 79 | 47% | 35% | 26% | 31% | 17% | NR | NR |
Christian et al | 18 | 66 | NR | NR | NR | NR | NR | NR | 0.49 |
Fernando et al | 1,541 | 65 | 45% | 34% | 28% | 15% | NR | NR | NR |
Goodman et al | 52 | 69 | 50% | 35% | 37% | 15% | 17% | NR | 23 |
Guenancia et al | 29 | 71 | 38% | 55% | 24% | NR | 21% | NR | NR |
Jacobs et al | 213 | 73 | 35% | NR | NR | NR | NR | NR | 97 |
Klouwenberg et al | 418 | 66 | 37% | NR | 21% | NR | NR | NR | 89 |
Lewis et al | 34 | 69 | 53% | 79% | 44% | 47% | 24% | 41% | NR |
Liu et al | 240 | 77 | 43% | 65% | 36% | 21% | 45% | 32% | 23.7 |
Makrygiannis et al | 20 | NR | 30% | 60% | 30% | 0 | 15% | 15% | 17.9 |
Moss et al | 749 | 64 | 45% | 66% | 32% | 19% | 31% | 12% | NR |
Shaver et al | 123 | 70 | 35% | 63% | 36% | 15% | 24% | 12% | NR |
Walkey et al | 2,896 | 74 | 44% | 46% | 28% | 11% | 5.7% | 4.4% | NR |
Walkey et al | 9,540 | 81 | 56% | 88% | 50% | 67% | 70% | 45% | NR |